Updates are available Correction dated 2025-02-07
Click to view Correction: https://doi.org/10.1038/s41467-025-56680-6
-
Authors
Shao, Fenli
Liu, Qianqian
Zhu, Yuyu https://orcid.org/0000-0002-6885-4083
Fan, Zhidan
Chen, Wenjun
Liu, Shijia
Li, Xiaohui
Guo, Wenjie
Feng, Gen-Sheng
Yu, Haiguo
Xu, Qiang
Sun, Yang https://orcid.org/0000-0003-1425-0089
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81704099)
National Natural Science Foundation of China (81673436)
National Natural Science Foundation of China (91853109)
National Natural Science Foundation of China (81872877)
National Natural Science Foundation of China (81730100)
- License Information
-
More Information
Article History
Received: 8 October 2020
Accepted: 21 October 2021
First Online: 11 November 2021
Change Date: 7 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-025-56680-6
Competing interests
: Y.S. and Q.X. have a patent pending on use of sonidegib in ankylosing spondylitis. The other authors declare no competing interests.
